Abstract:Objective To investigate the current status of diagnosis and treatment of embolic stroke of undetermined source (ESUS) in patients hospitalized for ischemic stroke in China. Methods A retrospective review of clinical data of inpatients for ischemic stroke in Peking University Third Hospital between Jan 2011 and Dec 2012 was conducted. Patients who did not receive 24-hour Holter monitoring, yet had completed the other evaluations and met ESUS diagnostic criteria of ESUS International Working Group were defined as "suspected ESUS"(sESUS), while those who completed all relative evaluations (including 24-hour Holter monitoring) and met the diagnostic criteria of ESUS were defined as "definite ESUS" (dESUS). All the above patients were enrolled into ESUS group, and the other subtypes of stroke as control. The baseline charateristics, risk factors and clinical features were compared between the two groups. Secondary prevention and stroke recurrence of these ESUS patients (including sESUS and dESUS) after discharge were followed up. Results Finally, 900 patients with ischemic stroke were enrolled in this study, of which 9 dESUS (1.0%) and 95 sESUS (10.6%), the 104 ESUS patients accounted for 11.6% (104/900) of all subjects,and the remaining 796 patients were divided into non-ESUS group. Clinical features of two groups as follows: 85 onset during physical activities (81.7%), 58 ones with fluctuating symptoms (55.8%) and the mean score of National Institutes of Health Stroke Scale (NIHSS) was 2.0 (0, 4.0) in ESUS group;the corresponding in control group was 538 (67.6%) , 245 (30.8%) and 3.0 (1.3, 5.0), respectively;there was significant difference in any of the three between two groups (P=0.010, P<0.001, P<0.001, respectively). Analyzing the usage of antithrombotic drugs in acute phase and after discharge in ESUS patients, we found that all ESUS patients had taken antiplatelet agents, and 6 dESUS and 10 sESUS patients experienced recurrent stroke during the first year after discharge. Conclusion Patients diagnosed as ESUS is very common in patients with ischemic stroke. Comparing with non-ESUS patients, there were more fluctuating symptoms and less neurologic deficit in ESUS ones. 24-hour Holter monitoring in ESUS patients is necessary and very helpful for determing the cause of stroke.

From cryptogenic to ESUS: Toward precision medicine?

Potential Role of 2-Phase Cardiac CT in Patients with Embolic Stroke of Undetermined Source

Embolic strokes of undetermined source: a clinical consensus statement of the ESC Council on Stroke, the European Association of Cardiovascular Imaging and the European Heart Rhythm Association of the ESC

Treat the patient, not the disease: The embolic stroke of undetermined source as an opportunity to optimize cardiovascular prevention in a holistic approach

Atrial Cardiomyopathy: An Emerging Cause of the Embolic Stroke of Undetermined Source

Different Clinical Phenotypes of Embolic Stroke of Undetermined Source: A Subgroup Analysis of 86 Patients

Human-induced Pluripotent Stem Cells As Models for Rare Cardiovascular Diseases: from Evidence-Based Medicine to Precision Medicine

Overview and Future Direction of Embolic Stroke of Undetermined Source from the Insights of CHALLENGE ESUS/CS Registry

Diagnosis and Treatment for embolic stroke of undetermined source: Consensus statement from the Taiwan stroke society and Taiwan society of cardiology

Embolic stroke of undetermined source: Focusing on atrial cardiopathy and patent foramen ovale

Abstract WP128: Using Clinical Data to Reclassify ESUS Patients to Either Large Artery Atherosclerotic or Cardioembolic Stroke Mechanisms

Secondary Stroke Prevention in Cryptogenic Stroke and Embolic Stroke of Undetermined Source (ESUS)

Prevalence of non-stenotic vulnerable carotid plaques in embolic stroke of undetermined source

Patent Foramen Ovale and Other Cardiopathies as Causes of Embolic Stroke With Unknown Source

Markers of Atrial Cardiopathy in Severe Embolic Strokes of Undetermined Source

The Future of Ischemic Stroke Diagnosis and a Review of Underrecognized Ischemic Stroke Etiologies

MRI in the Evaluation of Cryptogenic Stroke and Embolic Stroke of Undetermined Source

Current Status of Diagnosis and Treatment of Embolic Stroke of Undetermined Source

The Usefulness of Outpatient Cardiac Telemetry in Patients with Cryptogenic Stroke

Long-term outcomes of patients with embolic stroke of undetermined source according to subtype

Abstract TP209: Potential Embolic Sources Differ In Patients With Embolic Stroke Of Undetermined Source According To Age